# Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective

> Research article (ClinicoEconomics and Outcomes Research, 2022) · cited 14× · AI/ML

**Wikidata**: [openalex:W4225386815](https://www.wikidata.org/wiki/openalex:W4225386815)  
**Source**: https://4ort.xyz/entity/cost-effectiveness-and-budget-impact-analyses-of-tisagenlecleucel-in-pediatric-and-young-adult-patients-with-relapsed-or